Acquired resistance to coccidia is dependent on cell-mediated immune mechanisms (18) (19) (20) (21) (22) . Recent results indicate that C57BL/6 mice are susceptible and Swiss-Webster mice are resistant to Eimeria ferrisi Levine and Ivens 1965 (18) . The susceptible C57BL/6 strain became resistant after lymphocytes from E. ferrisi-resistant C57BL/6 mice or transfer factor was administered. Although there are many reports (1-3, 5, 8, 11, 12, 14, 17, 23, 29-32) on genetic differences in the immune response to different parasites, there are only limited reports on the genetic control of immunity to coccidiosis (7) .
E. ferrisi is an excellent coccidium for mouse immunity studies (18, 22 cecum and colon during a 10-day period (4, 9, 10; Blagburn et al., in press). Prepatency is 3 days and is followed by a 6-to 7-day patent period during which clinical signs are evident (18, 22) . Reduced growth rate, rough hair coat, bloody diarrhea, listlessness, inappetence, and death are the clinical signs of E. ferrisi infection in susceptible mice given as few as 100 oocysts. Mortality reaches its peak 5 to 8 days after oocyst inoculation, and the survivors are protected against challenge infection. Reduced ooycst production can also be used to measure immunity, but mortality is a more reliable measure because successive reduced oocyst production after challenge may not always be correlative. Also, complete immunity to oocyst reproduction is difficult to achieve with a virulent coccidium in some mouse strains (18 Infection. Qocysts from the stock cultures were diluted with water to provide infectious doses of 100, 500, 1,000, 5,000, 10,000, 50,000 and 100,000 in 0.5 ml. An infectious dose was defined as the number of sporulated oocysts of E. ferrisi per mouse. Calibrated stock culture of oocysts and the infectious doses were administered by stomach tube. Eight animals were in each group: six principal infection groups given doses from 100 to 50,000 oocysts and one control uninfected group per mouse strain. The progress of infections as indicated by clinical signs and mortality was followed for 10 days. Mice dying during this period were examined for the presence of coccidia by fecal and tissue examination. Where indicated, daily fecal oocyst outputs were determined by procedures previously described (18, 22) . In challenge experiments, infectious doses of 100,000 oocysts were given 14 days after infection to mice previously infected with 50,000 oocysts.
RAMTS. The effect of RAMTS (Microbiological Associates, Walkerville, Md.) on resistance to infection with E. ferrisi was tested in AKR mice. Mice were given 0.25 ml of anti-thymocyte serum subcutaneously at 2-day intervals beginning 10 days before coccidia challenge and 2 days after challenge with infectious doses of 500, 1,000, and 5,000 oocysts, and were given a final injection 2 days later. Control mice received normal rabbit serum. For each infectious dose, eight mice were given a total of seven injections of serum.
RESULTS
Comparison of susceptibility in different strains of mice. The mortality in 12 strains of mice infected with increasing infectious doses of E. ferrisi is shown in Table 1 . Mice of the random-bred Ha/ICR and inbred C57BL/6 strains were the most susceptible at nearly all dose levels. Mortality for all dose levels combined was 64% for C57BL/6 mice and 70% for Ha/ICR mice. As few as 100 oocysts killed 50% or more of the mice of both strains. Susceptible C57BL/6 mice usually died 5 to 6 days after infection; Ha/ICR mice usually died 9 to 10 days after infection. The inbred mice of CBA and DBA/2 strains were intermediate in susceptibility, with a mortality rate of about 20% for all dose levels combined. Infectious doses of 1,000 and 5,000 killed some mice, and the highest dose of 50,000 resulted in about 90% mortality for the combined strains. Susceptible CBA mice usually died 5 to 6 days after infection; DBA/2 mice died 9 to 10 days after infection. The mice of the inbred A/He, AKR, BALB/c, and C3H/Anf strains were the least susceptible, with less than 15% deaths for all dose levels combined. The highest infectious doses of 10,000 and 50,000 oocysts killed only 50% or less than 50% of the mice of these inbred strains.
The four F. hybrids (BALB/c x A/He)FI, (C57BL/6 x CBA)FI, (C57BL/6 x C3H/Anf)Fi, and C57BL/6 x DBA/2)F1 were more resistant than their inbred parent strains. In three of these hybrids, one parent was of the C57BL/6 strain, which was one of the most susceptible inbred strains. Only 10% or less of these hybrids died, a marked decrease from the 70% mortality in C57BL/6 mice. The other hybrid (BALB/c x A/He)Fl was more resistant than either of the parent strains.
Comparison of susceptibility in nu/nu and nu/+ BALB/c mice. Sixteen congenitally athymic nu/nu (nude) mice with BALB/c backgrounds and nu/+ BALB/c (normal) mice were infected with 50,000 E. ferrisi oocysts. Table 2 shows the daily oocyst output and the mortality of eight mice from each strain. The total output of oocysts of the nu/nu mice was markedly less than that of the nu/+ mice. The prepatent and patent periods were similar in both strains. E. ferrisi killed three of eight nu/nu mice 5 to 6 days after oocyst inoculation, but none of the nu/+ mice. A challenge infection of 100,000 oocysts in 14 days after the primary infection showed that nu/nu mice were highly susceptible to infection (Table 3 ). Oocyst output of the eight nu/nu mice due to challenge infection was about twice the output due to the primary infection, whereas the nu/+ mice showed about a 10-fold decrease in oocyst output. The challenge infection killed 50% of the nu/nu (nude) mice, but none of the nu/+ (normal) mice.
Effect of treatment with RAMTS on resistance of AKR mice. We needed to determine whether RAMTS reduced resistance of AKR mice to challenge infection. Infectious doses of 10,000 and 50,000 oocysts had been found previously to kill less than 50% of these 
DISCUSSION
The data presented show differences in susceptibility to coccidia infection among the various mice strains. Table 4 presents a summary of the strain differences found in susceptibility to E. ferrisi. Pronounced differences in mortality were evident between the susceptible C57BL/6 and Ha/ICR strains and the resistant A/He, AKR, BALB/c, and C3H/Anf strains. Mice of the CBA and DBA/2 strains were considered resistant, but were intermediate when compared with these other resistant strains. The use of a range of dose levels is important because differences in strain susceptibility may not be apparent at a low or high dose only. Inoculum size influenced strain susceptibility to toxoplasma in mice (5) . BALB/c mice infected with a low dose appeared to be the least susceptible strain, whereas BALB/c mice infected with a higher dose were the most susceptible strain. Because the inbred strains differ in their susceptibility, there must be a genetic component involved in the natural resistance to coccidia.
In this study, the results obtained from F1 hybrids support evidence for genetic control.
Experiments with F1 generations of C57BL/6 crossed with CBA, C3H/Anf, and DBA/2 show VOL. 26, 1979 that resistance is dominant. Also, F1 hybrids of naturally resistant BALB/c and A/He strains were resistant. At present, no conclusions can be drawn regarding the number of genes or their association with known loci of mouse genomes.
The immune response (Ir) genes associated with the H-2 locus govern the ability of the mouse to respond to a large number of antigens (6) . In this study, after comparison of the H-2 types (Table 4 ), no conclusion can be made as to the genomic location of resistance until a study is done with congenic strains of mice. However, resistance is not necessarily associated with H-2 genes as is resistance to Trypanosoma cruzi infection in mice (30) . Recently, results in two studies (10, 27) have shown that the protective effect of Mycobacterium bovis BCG against Schistosoma mansoni infection was not associated with the H-2 region and that the genetic control of delayed-type hypersensitivity to M. bovis may not be linked to the H-2 region.
Our previous studies (18, 22) (26) . However, few studies have considered the interaction of the nu gene and the inbred mouse strains in terms of susceptibility. We found that the C57BL/6 strain and Ha/ICR are susceptible to coccidia, yet the C57BL/6 strain has an antigen-dependent lymphocyte response to coccidia (18) . The C57BL/6 and Ha/ICR strains are not congenitally athymic or cell-mediated immunoincompetent. Recently, nu/nu BALB/c mice were naturally more resistant to Pseudomonas aeruginosa corneal infection than were the nu/+ BALB/c mice (16) . The mechanism of nu/nu resistance was not determined. Nevertheless, T-cell-dependent responses appear to be important in resistance to coccidia. Evidence for T-cell dependence was also found in experiments on AKR mice with mouse antithymocyte serum. Normal AKR mice that are resistant to challenge with 5000 oocysts became susceptible after treatment with the antiserum. However, the antiserum-treated mice remained resistant to lower doses of 500 and 1,000 oocysts. The effectiveness of the anti-thymocyte serum in the disruption of thymus-dependent activity might explain the absence of susceptibility to lower doses. Consideration of the genetic background of the strain remains important to some degree in influencing the resistance or susceptibility of mouse strains. Most evidence (15, 25, 26) rules out the role of antibody at least in passive protection against coccidia, but recent evidence for immunoglobulin A in immunity to coccidia has been reported (13) . Much remains to be answered concerning both the genetic control and mechanism of immunity to coccidia. The current data emphasize the importance of genetic factors and the degree of cell-mediated immune reactivity expressed in the protective response to coccidia.
